IPSEN’s $1.31 Billion Acquisition of Clementia Pharmaceuticals

Goodwin, Davies Ward Phillips & Vineberg, Skadden, Arps, Slate, Meagher and Flom LLP and Stikeman Elliott advised on the deal Ipsen (Euronext: IPN; ADR: IPSEY) executed…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here